High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment
Abstract
Previous studies on borderline resectable (BR) pancreatic cancer (PC) included patients with heterogenous preoperative states; however, the definition of resectability for PC has evolved. We aimed to investigate the prognostic factors for PC other than anatomical resectability in those who underwent upfront resection and discuss the optimal treatment strategy for PC.We retrospectively examined 431 patients who underwent upfront surgery with...
Paper Details
Title
High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment
Published Date
Jan 1, 2021
Journal
Volume
21
Issue
1
Pages
130 - 137
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History